Quick Answer
Aptevo Therapeutics Inc. reported Shares Outstanding of 997.8 thousand shares for fiscal year 2025.
Aptevo Therapeutics Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 997,830 | +24531.7% |
| 2024 | 4,051 | -66.1% |
| 2023 | 11,958 | -99.8% |
| 2022 | 6.47M | +32.0% |
| 2021 | 4.90M | +11.0% |
| 2020 | 4.41M | +36.4% |
| 2019 | 3.23M | -85.8% |
| 2018 | 22.81M | +5.6% |
| 2017 | 21.61M | +6.6% |
| 2016 | 20.27M | — |
| 2015 | 0 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 13.81M | -19.0% | +328.3% |
| June 30, 2025 | 3.22M | -21.0% | +121.1% |
| March 31, 2025 | 1.46M | +116.6% | +1900.1% |
| December 31, 2024 | 72,922 | -83.5% | -99.6% |
| September 30, 2024 | 17.05M | +17.9% | +317.8% |
| June 30, 2024 | 4.08M | -45.9% | +506.0% |
| March 31, 2024 | 673,430 | -90.7% | +52.2% |
| December 31, 2023 | 442,458 | -93.2% | -96.9% |
- Aptevo Therapeutics Inc. showed an increase of +24531.7% in Shares Outstanding compared to the prior fiscal year.
- The most recent figure is from Aptevo Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: